SCHEMBL24492899

SCHEMBL24492899

c1ccc(-n2c3ccccc3c3cc(-c4cc(-c5cccc(-c6cncc(-c7cncnc7)c6)c5)cc(-c5cccc(-c6cncc(-c7cncnc7)c6)c5)c4)ccc32)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 2/20 0.46
▸ L3MBTL1 Q9Y468 2/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ PTGER4 P35408 1/20 0.35
▸ NPY5R Q15761 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ CYP11B1 P15538 2/20 0.35
▸ CYP11B2 P19099 2/20 0.35
▸ IL1R1 P14778 1/20 0.35
▸ TSPO P30536 1/20 0.34
▸ MKNK1 Q9BUB5 1/20 0.34
▸ MKNK2 Q9HBH9 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ HDAC8 Q9BY41 1/20 0.34
▸ DHFR P00374 1/20 0.33
▸ RAC2 P15153 1/20 0.33
▸ RAC3 P60763 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24493239 0.97 ATM (0.49) ATML3MBTL1KDM4EPTGER4NPY5R
SCHEMBL16231279 0.89 ATM (0.45) ATML3MBTL1KDM4EPTGER4NPY5R
SCHEMBL24492826 0.89 KDM4E (0.45) ATML3MBTL1KDM4EKMT2ACYP11B1
SCHEMBL22252920 0.89 L3MBTL1 (0.45) ATML3MBTL1KDM4EPTGER4KMT2A
SCHEMBL24492827 0.89 KDM4E (0.45) ATML3MBTL1KDM4EPTGER4NPY5R
SCHEMBL11987839 0.88 L3MBTL1 (0.47) ATML3MBTL1KDM4EPTGER4KMT2A
SCHEMBL24492782 0.88 ATM (0.42) ATML3MBTL1KDM4EPTGER4NPY5R
SCHEMBL11981064 0.88 L3MBTL1 (0.53) ATML3MBTL1KDM4EPTGER4KMT2A
SCHEMBL11987828 0.88 L3MBTL1 (0.49) ATML3MBTL1KDM4EPTGER4NPY5R
SCHEMBL24492815 0.88 ATM (0.42) ATML3MBTL1KDM4ECYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220177454-A1 TRISUBSTITUTED BENZENE COMPOUND HAVING NITROGEN-CONTAINING HETERO RING IN MOLECULAR TERMINUS AND ORGANIC ELECTROLUMINESCENCE ELEMENT HODOGAYA CHEMICAL CO., LTD. (JP) 2022-06-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220177454-A1 TRISUBSTITUTED BENZENE COMPOUND HAVING NITROGEN-CONTAINING HETERO RING IN MOLECULAR TERMINUS AND ORGANIC ELECTROLUMINESCENCE ELEMENT ETV6, LEF1, TEAD2 ATM 3566/4885L3MBTL1 1418/4885KDM4E 688/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback